+ 33 1 46 99 68 20

 

A portfolio of essential medicines

Azactam®

Dosages and presentations

AZACTAM® 1 g. Powder for parenteral use.
Box of 1 vial. Box of 10 vials.
AZACTAM® 2 g. Powder for parenteral use.
Box of 1 vial
(Not all dosages and packagings are available in all countries)
p

Product information - Patient information leaflet

  • United Kingdom
  • United States
  • Active ingredient

    Aztreonam

    Marketing

    • Austria (dosage 1g, 2g. box of 1 vial)
    • Australia (dosage 1g, box of 10 vials)
    • Belgium, Luxemburg (dosage 1g, 2g, box of 1 vial)
    • Finland (dosage 1g, 2g. box of 1 vial)
    • France (dosage 1g, box of 1 vial)
    • Ireland (dosage 1g, 2g, box of 1 vial)
    • New Zealand (dosage 1g, box of 10 vials)
    • Norway (dosage 2g, box of 1 vial)
    • Portugal (dosage 1g, box of 1 vial)
    • Romania (dosage 1g, box of 1 vial)
    • Singapore (dosage 1g, box of 1 vial)
    • Spain (dosage 1g, box of 1 vial)
    • Sweden (dosage 1g, 2g. box of 1 vial)
    • Switzerland (dosage 2g, box of 1 vial)
    • United Kingdom (dosage 1g, 2g, box of 1 vial)
    • United States (dosage 1g, 2g, box of 10 vials)

    Product news

    Product available

    This information is intended for healthcare professionals.

    Our therapeutic areas

    and our main products

    Infectiology

    Amikacin

    Aztreonam

    Amoxicillin

    Xyllomac®

    (France)

    Delamoxyle®

    (Belgium - Luxembourg)

    Delamoxyl®

    (Switzerland)

    Amoxicillin and clavulanic acid

    Benzathine benzylpenicillin

    Extencilline®

    (France - Switzerland)

    Extencin®

    (Netherlands)

    Benzylpenicillin benzathine

    (United Kingdom)

    Oxacillin

    Istopen®

    (France)

    Penstapho®

    (Italy)

    Prostaphlin®

    (Czech Republic)

    Central nervous system

    Lithium carbonate
    Tropatépine hydrochloride
    Pipotiazine palmitic ester
    Lorazepam

    Other

    Histamine dihydrochloride
    Pipobroman
    N-acetylcysteine
    Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.

    REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT

    To request medical information on Delbert Pharma products or report an adverse event,
    please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20.

    This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.